Academic Journal
Q1Histopathology
About Histopathology
About Histopathology
Histopathology is a peer-reviewed scholarly journal published by Wiley-Blackwell Publishing Ltd (United Kingdom). It focuses on Q1. Publication coverage spans 1977-2026.
Key indicators: ISSN 1365-2559, 0309-0167; H-index 151.
Understanding This Journal's Metrics
Journal metrics help researchers assess fit, but they must be interpreted in context:
- H-index (151): Exceptionally high — 151 articles have each been cited at least 151 times. This indicates deep, sustained influence in the field.
Publishing in Histopathology
An established venue in its field. The journal welcomes solid, well-executed research. Ensure your manuscript fits the stated scope and follows author guidelines carefully.
- Scope fit: Confirm your research aligns with Q1. Off-scope manuscripts are typically desk-rejected quickly.
- Author guidelines: Follow formatting, reference style, and article-type requirements exactly — non-compliant manuscripts may be returned without review.
- Submission: Submit via the official journal website.
Is This Journal Right for Your Paper?
- Audience match: Will the journal's readers cite and build on your findings?
- Timeline: Higher-tier journals mean longer review and higher rejection risk. Balance prestige against your schedule.
- Indexing: Confirm indexing in Web of Science, Scopus, and PubMed (if biomedical) meets your institutional requirements.
- Open access needs: Check funder mandates and whether the journal offers compliant OA options.
Frequently Asked Questions
What is the ISSN of Histopathology?
1365-2559, 0309-0167.
Who publishes Histopathology?
Wiley-Blackwell Publishing Ltd.
What are Histopathology's metrics?
H-index 151.
Where do I submit to Histopathology?
Via the official website.
Is Histopathology peer-reviewed?
Yes — it is a peer-reviewed scholarly journal indexed in major academic databases.
Source-backed journal facts
Topics in published research
Sarcoma Diagnosis and Treatment; Lymphoma Diagnosis and Treatment; Breast Lesions and Carcinomas; Cancer and Skin Lesions; Breast Cancer Treatment Studies; Salivary Gland Tumors Diagnosis and Treatment.
OpenAlex classifies topics from published works. These topics are not the publisher’s official aims and scope.
Reported open-access list prices
4,840.00 USD; 4,070.00 EUR; 3,240.00 GBP
APC list prices reported by OpenAlex, which obtains this information from DOAJ. Confirm current charges, taxes, waivers and eligibility with the publisher; this is not a fee quotation.
Source: OpenAlex source record. Retrieved 2026-10-03. Source record updated 2026-10-02. OpenAlex metrics are different from SCImago metrics and the Clarivate Journal Impact Factor.
Journal Metrics
Quartile, SJR and the listed SCImago H-index use the 2025 imported SCImago dataset. A quartile may vary by subject category. Values without a source or reporting year are unverified historical entries. Verify the current Journal Impact Factor with Clarivate or the publisher before using it.
Aims & Scope
The publisher’s official aims and scope have not yet been verified for this profile. Use the journal website to check subject fit and accepted article types before submitting.
Recent Research Articles
Latest publications matched automatically by ISSN.
Alveolar soft part sarcoma of the female genital tract: a clinicopathological and molecular genetic study of 26 cases
Lu Zhao, Fengyi Zhang, Tangchen Yin, Meng Sun et al.
2026-10-13 · DOI: 10.1111/his.70302Detection of NTRK1/2/3 rearrangements in pigmented spindle cell naevus of Reed: a comparative study of optimized pan‐ TRK immunohistochemistry, FISH and RNA ‐ NGS
Costantino Ricci, Barbara Corti, Sara Coluccelli, Giulia Calafato et al.
2026-10-09 · DOI: 10.1111/his.70300Digital analysis of spatial expression of stromal fibroblast activation protein alpha (FAP) in DCIS
Ka Long Leung, Ronald C Chan, Conrad H Lee, Ngou‐Men Wong et al.
2026-10-09 · DOI: 10.1111/his.70292A rare postradiation vaginal vascular lesion: not an angiosarcoma
Min Han, Maria B. de Leon, Yu Liang, Matthew L. Hedberg et al.
2026-10-08 · DOI: 10.1111/his.70296Novel ALK ‐ EML4 fusion in a gastric gastrointestinal stromal tumour: towards emerging therapeutic options
Begoña O Alén, Begoña Sanromán‐Budiño, Antía Rodríguez‐López, Jorge Pombo‐Otero et al.
2026-10-08 · DOI: 10.1111/his.70299Cyclin‐dependent kinase 4/6 ( CDK4 /6) inhibitor‐induced hepatotoxicity and its resolution: a study of seven cases
Sunayana Misra, Lisa Centeno, Dupinder Singh, Romil Saxena et al.
2026-10-08 · DOI: 10.1111/his.70294Mitoses counting in phyllodes tumours: rationale for a standardized hotspot‐based approach
Edward Hadi, Mihir Gudi, Bill Li, Sandra O'Toole et al.
2026-10-08 · DOI: 10.1111/his.70293Do alternative classification systems improve prognostication in phyllodes tumours of the breast? A comparative clinicopathological study
Yuri Merlotti Gomes, João Pedro dos Reis da Costa, Roberto Bonfim Pimenta Peixoto, João Henrique Quintão et al.
2026-10-08 · DOI: 10.1111/his.70295Issue Information
2026-11 · DOI: 10.1111/his.70109Immunohistochemical profile of molecularly verified clear cell renal cell carcinomas
Kara S. Tanaka, Li Zhang, Chien‐Kuang Cornelia Ding, Nancy Y. Greenland et al.
2026-10-01 · DOI: 10.1111/his.70287Distinct Rb expression pattern in HPV ‐associated neuroendocrine carcinomas of the uterine cervix
Nobuko Yasutake, Misato Komamizu, Takeshi Iwasaki, Ryosuke Kuga et al.
2026-09-30 · DOI: 10.1111/his.70290Tumour deposits are associated with increased metastatic risk in colorectal cancer: a population‐based analysis of metastatic patterns and burden
Yao Shu, Nelleke P M Brouwer, Marloes A G Elferink, Johannes H W de Wilt et al.
2026-09-30 · DOI: 10.1111/his.70297Mixed neuroendocrine‐non‐neuroendocrine neoplasms, amphicrine‐like carcinoma and related lesions: a review of changes in classification and current concepts
Runjan Chetty, Anthony J Gill
2026-09-30 · DOI: 10.1111/his.70291Stroma AReactive Invasion Front Areas (SARIFA) is a negative prognostic factor for overall survival in non‐intestinal gastric adenocarcinomas
Ákos Jakab, Luca Szalai, Bettina Zengő, Ildikó Kocsmár et al.
2026-09-25 · DOI: 10.1111/his.70289Inter‐rater reliability of frozen donor liver macrovesicular steatosis assessment applying the Banff consensus method: a real‐world, multi‐specialty validation study
Derek M Loneman, Jarukit Tantipisit, Nicholas J Caldwell, Ting Zhao et al.
2026-09-25 · DOI: 10.1111/his.70283Immunoreactivity of GPNMB (glycoprotein nonmetastatic melanoma protein B) across the spectrum of uterine mesenchymal tumours
Josef Skopal, Marián Švajdler, Nikola Ptáková, Tomáš Vaněček et al.
2026-09-25 · DOI: 10.1111/his.70288Heterogeneity of breast and nodal response to neoadjuvant pembrolizumab‐based chemoimmunotherapy in early triple‐negative breast cancer and its clinical significance
Jiwon Koh, Koung Jin Suh, Hye Yeon Park, Hyun Jung Kwon et al.
2026-09-24 · DOI: 10.1111/his.70285Histopathology of nail unit tumours: diagnostic features and emerging advances
Angela J Jiang, Erika Koh, Cynthia Truong, Adam I Rubin et al.
2026-09-24 · DOI: 10.1111/his.70280Reviews
Community Reviews
Version History
October 9, 2026 at 7:07 pm
September 25, 2026